TY - JOUR
T1 - Practice points in gynecardiology
T2 - Abnormal uterine bleeding in premenopausal women taking oral anticoagulant or antiplatelet therapy
AU - Maas, Angela H.E.M.
AU - Euler, Mia Von
AU - Bongers, Marlies Y.
AU - Rolden, Herbert J.A.
AU - Grutters, Janneke P.C.
AU - Ulrich, Lian
AU - Schenck-Gustafsson, Karin
PY - 2015/12
Y1 - 2015/12
N2 - A growing number of premenopausal women are currently using antithrombotic and/or (dual) antiplatelet therapy for various cardiovascular indications. These may induce or exacerbate abnormal uterine bleeding and more awareness and knowledge among prescribers is required. Heavy and irregular menstrual bleeding is common in women in their forties and may have a variety of underlying causes that require different treatment options. Thus using anticoagulants in premenopausal women demands specific expertise and close collaboration between cardiovascular physicians and gynecologists. In this article we summarize the scope of the problem and provide practical recommendations for the care for young women taking anticoagulants and/or (dual) antiplatelet therapy. We also recommend that more safety data on uterine bleeding with novel anticoagulants in premenopausal women should be obtained.
AB - A growing number of premenopausal women are currently using antithrombotic and/or (dual) antiplatelet therapy for various cardiovascular indications. These may induce or exacerbate abnormal uterine bleeding and more awareness and knowledge among prescribers is required. Heavy and irregular menstrual bleeding is common in women in their forties and may have a variety of underlying causes that require different treatment options. Thus using anticoagulants in premenopausal women demands specific expertise and close collaboration between cardiovascular physicians and gynecologists. In this article we summarize the scope of the problem and provide practical recommendations for the care for young women taking anticoagulants and/or (dual) antiplatelet therapy. We also recommend that more safety data on uterine bleeding with novel anticoagulants in premenopausal women should be obtained.
KW - abnormal uterine bleeding
KW - antiplatelet therapy
KW - gynecardiology
KW - novel oral anticoagulants
KW - abnormale baarmoederbloeding
KW - antibloedplaatjestherapie
KW - gynaecardiologie
KW - nieuwe orale anticoagulantia
U2 - 10.1016/j.maturitas.2015.08.014
DO - 10.1016/j.maturitas.2015.08.014
M3 - Review article
C2 - 26358933
VL - 82
SP - 355
EP - 359
JO - Maturitas
JF - Maturitas
IS - 4
ER -